Ketoconazole and Adalat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ketoconazole (ketoconazole) and Adalat (nifedipine). Common drug interactions include abdominal pain among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Ketoconazole and Adalat. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Ketoconazole?

Ketoconazole has active ingredients of ketoconazole. It is often used in fungal infection. eHealthMe is studying from 16,014 Ketoconazole users. Check the latest studies of Ketoconazole.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

16 people who take Ketoconazole and Adalat together, and have interactions are studied.

Ketoconazole and Adalat drug interactions.

What are the common drug interactions of Ketoconazole and Adalat, by gender? *:

female:

  1. Abdominal pain
  2. Abdominal wall haematoma (abdominal wall blood clotting)
  3. Haemoglobin decreased
  4. Cataract (clouding of the lens inside the eye)
  5. Chronic kidney disease
  6. Renal failure (kidney dysfunction)
  7. Angina pectoris (chest pain due to ischemia of the heart muscle)
  8. Anxiety
  9. Blood glucose decreased
  10. Graft rejection (graft failure)

male:

  1. Alanine aminotransferase increased
  2. Blood bilirubin increased
  3. Drug abuser
  4. Haemoglobin decreased
  5. Headache (pain in head)
  6. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  7. Hepatocellular injury (liver injury)
  8. Hepatotoxicity (chemical-driven liver damage)
  9. Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

What are the common drug interactions of Ketoconazole and Adalat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Blood glucose decreased
  2. Graft rejection (graft failure)
  3. Sweating increased (excess sweating)

40-49:

n/a

50-59:

  1. Anxiety
  2. Chronic kidney disease
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Drug abuser
  5. Renal failure (kidney dysfunction)

60+:

  1. Haemoglobin decreased
  2. Abdominal pain
  3. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  4. Colon dysplasia (abnormal growth or development of cells of colon)
  5. Decreased appetite
  6. Dehydration (dryness resulting from the removal of water)
  7. Dizziness
  8. Headache (pain in head)
  9. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  10. Hepatocellular injury (liver injury)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 18.75%
  2. Pain: 3 people, 18.75%
  3. Cardiac Failure Chronic: 3 people, 18.75%
  4. Dyslipidaemia (abnormal amount of lipids): 3 people, 18.75%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 12.50%
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 12.50%
  7. Cardiac Failure: 2 people, 12.50%
  8. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 2 people, 12.50%
  9. Diabetes: 2 people, 12.50%
  10. Blood Calcium Decreased: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ketoconazole and Adalat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ketoconazole and Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ketoconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ketoconazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adalat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ketoconazole and nifedipine (the active ingredients of Ketoconazole and Adalat, respectively), and Ketoconazole and Adalat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: